ScholarIQanswers from OpenAlex
Vertex Pharmaceuticals (United States)
InstitutionResearch output, impact & collaborations
Vertex Pharmaceuticals (United States) is a institution indexed in ScholarIQ from OpenAlex.
What is known about Vertex Pharmaceuticals (United States)?
ScholarIQrecord summary
Vertex Pharmaceuticals (United States) is a research organisation in Boston, US. OpenAlex records 2,834 works and 853,801 citations for it. 1,064 researchers list it as their most recent affiliation.
How many works does Vertex Pharmaceuticals (United States) have?
ScholarIQindexed works
Vertex Pharmaceuticals (United States) has 2,834 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Vertex Pharmaceuticals (United States) have?
ScholarIQcitation count
Vertex Pharmaceuticals (United States) has 853,801 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Vertex Pharmaceuticals (United States)?
ScholarIQresearcher count
Vertex Pharmaceuticals (United States) has 1,064 researchers in the ScholarIQ index.
What is the average h-index at Vertex Pharmaceuticals (United States)?
ScholarIQavg h-index
Vertex Pharmaceuticals (United States) has an average h-index of 88 in OpenAlex.
What is the ROR of Vertex Pharmaceuticals (United States)?
ScholarIQror
The ROR for Vertex Pharmaceuticals (United States) is on the source record.
What is the OpenAlex record for Vertex Pharmaceuticals (United States)?
ScholarIQopenalex
The OpenAlex for Vertex Pharmaceuticals (United States) is on the source record.
What is the Wikidata of Vertex Pharmaceuticals (United States)?
ScholarIQwikidata
The Wikidata for Vertex Pharmaceuticals (United States) is on the source record.
Who are the most-cited researchers behind Vertex Pharmaceuticals (United States)?
ScholarIQtop researchers by citations
What are the most-cited papers on Vertex Pharmaceuticals (United States)?
ScholarIQmost cited works
Genome-Wide Association Analysis Identifies Loci for Type 2 Diabetes and Triglyceride Levels
Richa Saxena, Benjamin F. Voight, Valeriya Lyssenko, Noël P. Burtt, Paul I. W. de Bakker, Hong Chen, Jeffrey J. Roix, Sekar Kathiresan, Joel N. Hirschhorn, Mark J. Daly, Thomas E. Hughes, Leif Groop, David Altshuler, Peter Almgren, José C. Florez, Joanne M. Meyer, Kristin Ardlie, Kristina Bengtsson Boström, Bo Isomaa, Guillaume Lettre, Ulf Lindblad, Helen N. Lyon, Olle Melander, Christopher Newton‐Cheh, Peter M. Nilsson, Marju Orho‐Melander, Lennart Råstam, Elizabeth K. Speliotes, Marja‐Riitta Taskinen, Tiinamaija Tuomi, Candace Guiducci, Anna Berglund, Joyce Carlson, Lauren Gianniny, Rachel Hackett, Liselotte Hall, Johan Holmkvist, Esa Laurila, Marketa Sjögren, Maria Sterner, Aarti Surti, Margareta Svensson, Malin Svensson, Ryan Tewhey, Brendan Blumenstiel, Melissa Parkin, Matthew DeFelice, Rachel Barry, Wendy Brodeur, Jody Camarata, Nancy Chia, Mary Fava, John G. Gibbons, B. Handsaker, Claire M. Healy, Christine Nguyen, Casey Gates, Carrie Sougnez, Diane Gage, Marcia M. Nizzari, Stacey Gabriel, Gung‐Wei Chirn, Qicheng Ma, Hemang Parikh, Delwood Richardson, Darrell Ricke, Shaun Purcell
Association between Microdeletion and Microduplication at 16p11.2 and Autism
Lauren A. Weiss, Yiping Shen, Joshua M. Korn, Dan E. Arking, David T. Miller, Ragnheiður Fossdal, Evald Sæmundsen, Hreinn Stefánsson, Manuel A.R. Ferreira, Todd Green, Orah S. Platt, Douglas M. Ruderfer, Christopher A. Walsh, David Altshuler, Aravinda Chakravarti, Rudolph E. Tanzi, Kari Stefansson, Susan L. Santangelo, James F. Gusella, Pamela Sklar, Bai-Lin Wu, Mark J. Daly
Assessing the impact of population stratification on genetic association studies
Matthew L. Freedman, David Reich, Kathryn L. Penney, Gavin J. McDonald, André A. Mignault, Nick Patterson, Stacey Gabriel, Eric J. Topol, Jordan W. Smoller, Carlos N. Pato, Michele T. Pato, Tracey L. Petryshen, Laurence N. Kolonel, Eric S. Lander, Pamela Sklar, Brian E. Henderson, Joel N. Hirschhorn, David Altshuler
Multiple regions within 8q24 independently affect risk for prostate cancer
Christopher A. Haiman, Nick Patterson, Matthew L. Freedman, Simon Myers, Malcolm C. Pike, Alicja Waliszewska, Julie Neubauer, Arti Tandon, Christine Schirmer, Gavin J. McDonald, Steven C. Greenway, Daniel O. Stram, Loı̈c Le Marchand, Laurence N. Kolonel, Melissa A. Frasco, David Wong, Loreall Pooler, Kristin Ardlie, Ingrid Oakley‐Girvan, Alice S. Whittemore, Kathleen A. Cooney, Esther M. John, Sue A. Ingles, David Altshuler, Brian E. Henderson, David Reich
Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men
Matthew L. Freedman, Christopher A. Haiman, Nick Patterson, Gavin J. McDonald, Arti Tandon, Alicja Waliszewska, Kathryn L. Penney, Robert Steen, Kristin Ardlie, Esther M. John, Ingrid Oakley‐Girvan, Alice S. Whittemore, Kathleen A. Cooney, Sue A. Ingles, David Altshuler, Brian E. Henderson, David Reich
How much of the research on Vertex Pharmaceuticals (United States) is open access?
ScholarIQopen access share
60%OPEN ACCESS